Activated protein C (APC) acts as a potent anticoagulant enzyme by inactivating Factor V and Factor VIII. In this study, protein S was shown to increase the inactivation of purified Factor VIII by APC ninefold. The reaction rate was saturated with respect to the concentration of protein S when protein S was present in a 10-fold molar excess over APC. The heavy chain of Factor VIII was cleaved by APC and protein S did not alter the degradation pattern. Factor VIII circulates in a complex with the adhesive protein von Willebrand factor. When purified Factor VIII was recombined with von Willebrand factor, the inactivation of Factor VIII by APC proceeded at a 10-20-fold slower rate as compared with Factor VIII in the absence of von Willebrand factor. Protein S had no effect on the inactivation of the Factor VIII-von Willebrand factor complex by APC. After treatment of this complex with thrombin, however, the actions of APC and protein S towards Factor VIII were completely restored. In hemophilia A plasma, purified Factor VIII associated with endogenous von Willebrand factor, resulting in a complete protection against APC (4 nM). By mixing hemophilic plasma with plasma from a patient with severe von Willebrand's disease, we could vary the amount of von Willebrand factor. 1 U of von Willebrand factor was needed to provide protection of 1 U Factor VIII. Also in plasma from patients with the IIA-type variant of von Willebrand's disease, Factor VIII was protected. In von Willebrand's disease plasma, which was depleted of protein S, APC did not inactivate Factor VIII. These results indicate that protein S serves as a cofactor in the inactivation of Factor VIII and Factor VIIIa by APC and that von Willebrand factor can regulate the action of these two anticoagulant proteins.
J A Koedam, J C Meijers, J J Sixma, B N Bouma
Title and authors | Publication | Year |
---|---|---|
Complement or insult: the emerging link between complement cascade deficiencies and pathology of myeloid malignancies.
Oakes A, Liu Y, Dubielecka PM |
Journal of leukocyte biology | 2024 |
circ_0001274 competitively binds miR-143-3p to up-regulate VWF expression to improve acute traumatic coagulopathy
Yong Luo, Yong Fu, Ning Yang, Jian Zeng, Taifa Tan, Jun Hu, Fang Li, Liang Zeng, Wenchao Zhang, Zhanchen Liao, Zhigang Luo, Jian Peng |
Oxidative medicine and cellular longevity | 2023 |
Dysregulation of Protein S in COVID-19
Sim MM, Wood JP |
Best practice & research. Clinical haematology | 2022 |
Proteomics changes after negative pressure wound therapy in diabetic foot ulcers
Z Jia, L Liu, S Zhang, X Zhao, L Luo, Y Tang, B Shen, M Chen |
Molecular medicine reports | 2021 |
Acquired von Willebrand syndrome in patients with monoclonal gammopathy of undetermined significance investigated using a mechanistic approach.
Galletta E, Galvanin F, Bertomoro A, Daidone V, Casonato A |
Blood transfusion = Trasfusione del sangue | 2021 |
Pediatric Surgery: A Comprehensive Textbook for Africa
EA Ameh, SW Bickler, K Lakhoo, BC Nwomeh, D Poenaru |
2020 | |
FVIII/VWF complex displays a greater pro‐haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell‐based models
CT Ammollo, F Semeraro, A Vitulli, L Dirienzo, AM Mezzasoma, N Semeraro, P Gresele, M Colucci |
Haemophilia : the official journal of the World Federation of Hemophilia | 2020 |
Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients
LL Swystun, K Ogiwara, O Rawley, C Brown, I Georgescu, W Hopman, V Labarque, C Male, K Thom, VS Blanchette, MD Carcao, D Lillicrap |
Blood | 2019 |
Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based study
FJ Wolters, J Boender, PS de Vries, MA Sonneveld, PJ Koudstaal, MP de Maat, OH Franco, MK Ikram, FW Leebeek, MA Ikram |
Scientific Reports | 2018 |
An intronic mutation c.6430-3C>G in the F8 gene causes splicing efficiency and premature termination in hemophilia A:
Z Xia, J Lin, L Lu, C Kim, P Yu, M Qi |
Blood Coagulation & Fibrinolysis | 2018 |
Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis
K Kedia, JP Wendler, ES Baker, KE Burnum-Johnson, LG Jarsberg, KG Stratton, AT Wright, PD Piehowski, MA Gritsenko, DM Lewinsohn, GB Sigal, MH Weiner, RD Smith, JM Jacobs, P Nahid |
Tuberculosis (Edinburgh, Scotland) | 2018 |
Immune Hematology
JM Despotovic |
2018 | |
Hematology - Latest Research and Clinical Advances
M Guenova, G Balatzenko |
2018 | |
A factor VIII–nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation
V Muczynski, C Casari, F Moreau, G Aymé, C Kawecki, P Legendre, V Proulle, OD Christophe, CV Denis, PJ Lenting |
Blood | 2018 |
Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice
LL Swystun, I Georgescu, J Mewburn, M Deforest, K Nesbitt, K Hebert, C Dwyer, C Brown, C Notley, D Lillicrap |
Journal of Thrombosis and Haemostasis | 2017 |
Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis
TT Jiang, LY Shi, LL Wei, X Li, S Yang, C Wang, CM Liu, ZL Chen, HH Tu, ZJ Li, JC Li, S Kumar |
PloS one | 2017 |
Type 2N von Willebrand disease: Characterization and diagnostic difficulties
A Casonato, E Galletta, L Sarolo, V Daidone |
Haemophilia : the official journal of the World Federation of Hemophilia | 2017 |
THE COAGULATION FACTOR VIII: STRUCTURE AND APPLICATION
N Shurko, T Danysh, V Novak |
2017 | |
Amino-Terminal Fusion of Epidermal Growth Factor 4,5,6 Domains of Human Thrombomodulin on Streptokinase Confers Anti-Reocclusion Characteristics along with Plasmin-Mediated Clot Specificity
N Maheshwari, S Kantipudi, A Maheshwari, K Arora, Vandana, N Kwatra, G Sahni, A Bouchama |
PloS one | 2016 |
FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes
A der Flier, Z Liu, S Tan, K Chen, D Drager, T Liu, S Patarroyo-White, H Jiang, DR Light, CB Doering |
PloS one | 2015 |
Attenuating a sickle cell crisis with annexin V
JR Kennedy |
Medical Hypotheses | 2015 |
Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban
A Tripodi, I Martinelli, V Chantarangkul, M Clerici, A Artoni, S Passamonti, F Peyvandi |
International Journal of Hematology | 2015 |
An update on type 2B von Willebrand disease
S Mikhail, ES Aldin, M Streiff, A Zeidan |
Expert Review of Hematology | 2014 |
Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives
SN Tchaikovski, MC Thomassen, SD Costa, K Bremme, J Rosing |
Thrombosis Research | 2014 |
Novel factor V mutation (W1920R, FV Nara) associated with serious deep vein thrombosis and APC resistance : The plot thickens
K SHINOZAWA, K NOGAMI |
Japanese Journal of Thrombosis and Hemostasis | 2014 |
Von Willebrand Disease: Range of the Disease, and Management
KS Fernández, PA Alarcón |
Current Pediatrics Reports | 2013 |
Blood Clotting Factor VIII: From Evolution to Therapy
NA Orlova, SV Kovnir, II Vorobiev, AG Gabibov, AI Vorobiev |
Acta Naturae | 2013 |
Phenotypic implications of a co-existent haemorrhagic and thrombotic genotype :
J Thachil, V Martlew |
Blood Coagulation & Fibrinolysis | 2012 |
Management of bleeding disorders: basic science : BASIC SCIENCE OF BLEEDING DISORDERS MANAGEMENT
FA Ofosu, E Santagostino, S Grancha, P Marco |
Haemophilia | 2012 |
Thrombosis in VonWillebrand disease
W Qureshi, S Hassan, V Dabak, P Kuriakose |
Thrombosis Research | 2012 |
The fraction of recombinant factor VIII:Ag unable to bind von Willebrand factor has no FVIII coagulant activity: studies in vitro
FA Ofosu, H Tse, A Naqvi, H Bhakta, Y Song |
Haemophilia | 2012 |
Von Willebrand Disease
PM Mannucci, M Franchini |
Von Willebrand Disease | 2011 |
Advances in Clinical Chemistry
M Mahler |
Advances in Clinical Chemistry Volume 54 | 2011 |
Clinical efficacy of a novel VWF-containing FVIII concentrate, Wilate®, in the prophylaxis and treatment of bleeding episodes in previously treated haemophilia A patients
A Klukowska, J Windyga, A Batorova |
Thrombosis Research | 2011 |
Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia :
SN Tchaikovski, MC Thomassen, SD Costa, LL Peeters, J Rosing |
Thrombosis and Haemostasis | 2011 |
Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma
C Maas, JC Meijers, JA Marquart, K Bakhtiari, C Weeterings, PG de Groot, RT Urbanus |
Proceedings of the National Academy of Sciences | 2010 |
Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
TC Nichols, DA Bellinger, EP Merricks, RA Raymer, MT Kloos, N Defriess, MV Ragni, TR Griggs |
Thrombosis | 2010 |
Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance
V Terraube, JS O’donnell, PV Jenkins |
Haemophilia | 2010 |
C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies
A Buil, DA Trégouët, JC Souto, N Saut, M Germain, M Rotival, L Tiret, F Cambien, M Lathrop, T Zeller, MC Alessi, SR de Cordoba, T Münzel, P Wild, J Fontcuberta, F Gagnon, J Emmerich, L Almasy, S Blankenberg, JM Soria, PE Morange |
Blood | 2010 |
Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals
LF Maurissen, E Castoldi, P Simioni, J Rosing, TM Hackeng |
Journal of Thrombosis and Haemostasis | 2010 |
Effects of endothelin-1 and phenylephrine on plasma levels of von Willebrand factor and protein S
GC Leitner, L Schmetterer, S Kapiotis, B Jilma |
Thrombosis Research | 2010 |
Characterization of factor VIII pharmaceutical preparations by means of MudPIT proteomic approach
F Basilico, I Nardini, F Mori, E Brambilla, L Benazzi, AD Palma, E Rosti, C Farina, PL Mauri |
Journal of Pharmaceutical and Biomedical Analysis | 2010 |
Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells
M Biggelaar, EA Bouwens, NA Kootstra, RP Hebbel, J Voorberg, K Mertens |
Haematologica | 2009 |
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency
TC Nichols, AM Dillow, HW Franck, EP Merricks, RA Raymer, DA Bellinger, VR Arruda, KA High |
ILAR journal / National Research Council, Institute of Laboratory Animal Resources | 2009 |
Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions
C Sugita, A Yamashita, S Moriguchi-Goto, E Furukoji, M Takahashi, A Harada, T Soeda, T Kitazawa, K Hattori, S Tamura, Y Asada |
Thrombosis Research | 2009 |
Pregnancy-associated changes in the hemostatic system in wild-type and factor V Leiden mice
SN Tchaikovski, BJ van Vlijmen, AC Cleuren, MC Thomassen, V Tchaikovski, G Tans, J Rosing |
Journal of Thrombosis and Haemostasis | 2009 |
Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A
S Lacroix-Desmazes, AM Navarrete, S Andre, J Bayry, SV Kaveri, S Dasgupta |
Blood | 2008 |
The disappearing act of factor VIII
PJ Lenting, OD Christophe, P Guéguen |
Haemophilia | 2008 |
Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo
CJ van Schooten, S Shahbazi, E Groot, BD Oortwijn, HM van Berg, CV Denis, PJ Lenting |
Blood | 2008 |
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
LF Maurissen, MC Thomassen, GA Nicolaes, B Dahlback, G Tans, J Rosing, TM Hackeng |
Blood | 2008 |
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate®P/ Humate®-P: History and clinical performance
E Berntorp, W Archey, G Auerswald, AB Federici, M Franchini, S Knaub, W Kreuz, S Lethagen, PM Mannucci, H Pollmann, I Scharrer, K Hoots |
European Journal of Haematology | 2008 |
Detailed Mechanisms of the Inactivation of Factor VIIIa by Activated Protein C in the Presence of Its Cofactors, Protein S and Factor V
AJ Gale, TJ Cramer, D Rozenshteyn, JR Cruz |
The Journal of biological chemistry | 2008 |
Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors
BM Reipert, PM van Helden, HP Schwarz, C Hausl |
British Journal of Haematology | 2007 |
Multiple congenital coagulopathies co-expressed with Von Willebrand’s disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature
E Asatiani, CM Kessler |
Haemophilia | 2007 |
Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A
N Bogdanova, A Markoff, R Eisert, C Wermes, H Pollmann, A Todorova, M Chlystun, U Nowak-Göttl, J Horst |
Human Mutation | 2007 |
Nonhemophilic Inhibitors of Coagulation
BM Ewenstein |
Consultative Hemostasis and Thrombosis | 2007 |
Consultative Hemostasis and Thrombosis
VJ Marder |
Consultative Hemostasis and Thrombosis | 2007 |
Protein S Multimers Are Generated In Vitro and Affect Protein S Structure-Function Analyses
KM Seré, GM Willems, J Rosing, TM Hackeng |
Seminars in Hematology | 2006 |
Characterization of Factor VIII Inhibitors
M Shima |
International Journal of Hematology | 2006 |
Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count
T Lisman, J Adelmeijer, S Cauwenberghs, EC van Pampus, JW Heemskerk, PG de Groot |
Journal of Thrombosis and Haemostasis | 2005 |
Comparative Measurement of Anti-Factor VIII Antibody by Bethesda Assay and ELISA Reveals Restricted Isotype Profile and Epitope Specificity
F Towfighi, S Gharagozlou, RA Sharifian, A Kazemnejad, K Esmailzadeh, MR Managhchi, F Shokri |
Acta Haematologica | 2005 |
Lack of desmopressin (DDAVP) response in men with hemophilia A following liver transplantation
PA Lamont, MV Ragni |
Journal of Thrombosis and Haemostasis | 2005 |
Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions
K Tomokiyo, Y Kamikubo, T Hanada, T Araki, Y Nakatomi, Y Ogata, SM Jung, T Nakagaki, M Moroi |
Blood | 2005 |
Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-PR)
AR Thompson, JC Gill, BM Ewenstein, G Mueller-Velten, BA Schwartz |
Haemophilia | 2004 |
Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates
Y Lin, X Yang, MC Chevrier, S Craven, TW Barrowcliffe, R Lemieux, FA Ofosu |
Haemophilia | 2004 |
Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals*
MJ Heeb, RR Koenen, JA Fernandez, TM Hackeng |
Journal of Thrombosis and Haemostasis | 2004 |
Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance
KM Seré, J Rosing, TM Hackeng |
Blood | 2004 |
Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generation
T Lisman, J Adelmeijer, HF Heijnen, PG de Groot |
Blood | 2004 |
Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)
JE Kaufmann, UM Vischer |
Journal of Thrombosis and Haemostasis | 2003 |
A study on associations between antiprothrombin antibodies, antiplasminogen antibodies and thrombosis
MJ Simmelink, PG de Groot, RH Derksen |
Journal of Thrombosis and Haemostasis | 2003 |
Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-PR): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy
JC Gill, BM Ewenstein, AR Thompson, G Mueller-Velten, BA Schwartz |
Haemophilia | 2003 |
Recombinant factor VIIa enhances deposition of platelets with congenital or acquired αIIbβ3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor–independent thrombin generation
T Lisman, S Moschatsis, J Adelmeijer, HK Nieuwenhuis, PG Groot |
Blood | 2003 |
The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation
RR Koenen, G Tans, R van Oerle, K Hamulyák, J Rosing, TM Hackeng |
Blood | 2003 |
Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families
J Esparza-Gordillo, JM Soria, A Buil, JC Souto, L Almasy, J Blangero, J Fontcuberta, SR de Córdoba |
Immunogenetics | 2003 |
Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II
MJ Simmelink, JA Fernandez, RH Derksen, JH Griffin, PG de Groot |
British Journal of Haematology | 2002 |
Activated Protein C-Dependent and –Independent Anticoagulant Activities of Protein S Have Different Structural Requirements
MJ Heeb, JH Griffin |
Blood Cells, Molecules, and Diseases | 2002 |
Structural Requirements of Anticoagulant Protein S for Its Binding to the Complement Regulator C4b-binding Protein
TK Giri, S Linse, PG de Frutos, T Yamazaki, BO Villoutreix, B Dahlbäck |
The Journal of biological chemistry | 2002 |
Pan Vascular Medicine
P Lanzer, EJ Topol |
2002 | |
Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces
MJ Simmelink, DA Horbach, RH Derksen, JC Meijers, EM Bevers, GM Willems, PG de Groot |
British Journal of Haematology | 2001 |
The molecular biology of von Willebrand disease
S Keeney, AM Cumming |
Clinical and Laboratory Haematology | 2001 |
Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology
C Mazurier, J Goudemand, L Hilbert, C Caron, E Fressinaud, D Meyer |
Best Practice & Research Clinical Haematology | 2001 |
Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C–mediated proteolysis
K Nogami, M Shima, JC Giddings, K Hosokawa, M Nagata, S Kamisue, H Suzuki, M Shibata, EL Saenko, I Tanaka, A Yoshioka |
Blood | 2001 |
Purified Protein S Contains Multimeric Forms with Increased APC-Independent Anticoagulant Activity
KM Seré, MP Janssen, GM Willems, G Tans, J Rosing, TM Hackeng |
Biochemistry | 2001 |
HEMORRHAGIC PROBLEMS IN OBSTETRICS, EXCLUSIVE OF DISSEMINATED INTRAVASCULAR COAGULATION
FA Nizzi, G Mues |
Hematology/Oncology Clinics of North America | 2000 |
Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor–deficient mice
HP Schwarz, PJ Lenting, B Binder, J Mihaly, C Denis, F Dorner, PL Turecek |
Blood | 2000 |
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor
M Jacquemin, R Lavend'homme, A Benhida, B Vanzieleghem, R d'Oiron, JM Lavergne, HH Brackmann, R Schwaab, T VandenDriessche, MK Chuah, M Hoylaerts, JG Gilles, K Peerlinck, J Vermylen, JM Saint-Remy |
Blood | 2000 |
Self-Association of Human Protein S
JE Pauls, MF Hockin, GL Long, KG Mann |
Biochemistry | 2000 |
High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C
JH Griffin, K Kojima, CL Banka, LK Curtiss, JA Fernández |
Journal of Clinical Investigation | 1999 |
C4b-Binding Protein (C4BP) β-Chain Short Consensus Repeat-2 Specifically Contributes to the Interaction of C4BP with Protein S
RH van de Poel, JC Meijers, B Dahlbäck, BN Bouma |
Blood Cells, Molecules, and Diseases | 1999 |
Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system
AL Prieto, JL Weber, S Tracy, MJ Heeb, C Lai |
Brain Research | 1999 |
Catalytic activity of antibodies against factor VIII in patients with hemophilia A
S Lacroix-Desmazes, A Moreau, Sooryanarayana, C Bonnemain, N Stieltjes, A Pashov, Y Sultan, J Hoebeke, MD Kazatchkine, SV Kaveri |
Nature Medicine | 1999 |
Interaction between Protein S and Complement C4b-binding Protein (C4BP): AFFINITY STUDIES USING CHIMERAS CONTAINING C4BP β-CHAIN SHORT CONSENSUS REPEATS
RH van de Poel, JC Meijers, BN Bouma |
The Journal of biological chemistry | 1999 |
Antithrombotics
AC Uprichard, KP Gallagher |
1999 | |
Laboratory Techniques in Thrombosis - a Manual
J Jespersen, RM Bertina, F Haverkate |
1999 | |
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
HF Heijnen, AE Schiel, R Fijnheer, HJ Geuze, JJ Sixma |
Blood | 1999 |
Can we improve on nature? "Super molecules" of factor VIII
RJ Kaufman, SW Pipe |
Haemophilia | 1998 |
Summary of a workshop on potency and dosage of von Willebrand factor concentrates
Chang, Rick, L. Ross Pierce, Weinstein |
Haemophilia | 1998 |
Pharmacokinetics, efficacy and safety of Humate-P®in von Willebrand disease
Dobrkovska, Krzensk, Chediak |
Haemophilia | 1998 |
Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain
MV Wijnen, JG Stam, GT Chang, JC Meijers, PH Reitsma, RM Bertina, BN Bouma |
Biochemical Journal | 1998 |
Involvement of Amino Acid Residues 423–429 of Human Protein S in Binding to C4b-Binding Protein
JA Fernández, JH Griffin, GT Chang, J Stam, PH Reitsma, RM Bertina, BN Bouma |
Blood Cells, Molecules, and Diseases | 1998 |
Chemical synthesis of human protein S thrombin-sensitive module and first epidermal growth factor module
TM Hackeng, PE Dawson, SB Kent, JH Griffin |
Biopolymers | 1998 |
The Role of Platelet Von Willebrand Factor in the Binding of Factor VIII to Activated Platelets
H Suzuki, M Shima, S Kamisue, H Nakai, K Nogami, M Shibata, S Morichika, I Tanaka, JC Giddings, A Yoshioka |
Thrombosis Research | 1998 |
The Life Cycle of Coagulation Factor VIII in View of Its Structure and Function
PJ Lenting, JA van Mourik, K Mertens |
Blood | 1998 |
The Structure and Function of Murine Factor V and Its Inactivation by Protein C
TL Yang, J Cui, A Rehumtulla, A Yang, M Moussalli, RJ Kaufman, D Ginsburg |
Blood | 1998 |
A Novel Mutation in the D3 Domain of von Willebrand Factor Markedly Decreases Its Ability to Bind Factor VIII and Affects Its Multimerization
S Jorieux, C Gaucher, J Goudemand, C Mazurier |
Blood | 1998 |
Physiology of the Acute Wound
WT Lawrence |
Clinics in Plastic Surgery | 1998 |
von Willebrand Disease
WC Nichols, D Ginsburg |
Medicine | 1997 |
Transgenic pigs produce functional human factor VIII in milk
RK Paleyanda, WH Velander, TK Lee, DH Scandella, FC Gwazdauskas, JW Knight, LW Hoyer, WN Drohan, H Lubon |
Nature Biotechnology | 1997 |
von Willebrand Disease:
WC Nichols, D Ginsburg |
Medicine | 1997 |
Intrinsic Anticoagulation: Protein C, Protein S, and Thrombomodulin
JL Hale, N Nathan, M D'Ambra |
Seminars in cardiothoracic and vascular anesthesia | 1997 |
Inhibitory Mechanism of the Protein C Pathway on Tissue Factor-induced Thrombin Generation: SYNERGISTIC EFFECT IN COMBINATION WITH TISSUE FACTOR PATHWAY INHIBITOR
C Veer, NJ Golden, M Kalafatis, KG Mann |
The Journal of biological chemistry | 1997 |
Increased Tissue Factor-initiated Prothrombin Activation as a Result of the Arg 506 → Gln Mutation in Factor V LEIDEN
C Veer, M Kalafatis, RM Bertina, P Simioni, KG Mann |
The Journal of biological chemistry | 1997 |
26. Hämophilie-Symposion 1995
I Scharrer, W Schramm |
1997 | |
An In Vitro Analysis of the Combination of Hemophilia A and Factor VLEIDEN
C van t Veer, NJ Golden, M Kalafatis, P Simioni, RM Bertina, KG Mann |
Blood | 1997 |
Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII
ME Rick, DM Krizek |
American Journal of Hematology | 1996 |
Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin
TM Hackeng, G Tans, SJ Koppelman, PG de Groot, J Rosing, BN Bouma |
Biochemical Journal | 1996 |
Factor VIII C2 Domain Missense Mutations Exhibit Defective Trafficking of Biologically Functional Proteins
SW Pipe, RJ Kaufman |
The Journal of biological chemistry | 1996 |
Pathogenesis, Clinical Picture and Treatment of von Willebrand's Disease
SR Lethagen |
Annals of Medicine | 1995 |
Expression and Functional Characterization of Chimeras Between Human and Bovine Vitamin-K-dependent Protein-S-defining Modules Important for the Species Specificity of the Activated Protein C Cofactor Activity
X He, L Shen, B Dahlback |
European Journal of Biochemistry | 1995 |
Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras
TC Nichols, CM Samama, DA Bellinger, J Roussi, RL Reddick, M Bonneau, MS Read, O Bailliart, GG Koch, M Vaiman |
Proceedings of the National Academy of Sciences | 1995 |
Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry
J Spaargaren, PL Giesen, MP Janssen, J Voorberg, GM Willems, JA van Mourik |
Biochemical Journal | 1995 |
Cofactors V and VIII after endotoxin administration to human volunteers
EG Wyshock, AF Suffredini, JE Parrillo, RW Colman |
Thrombosis Research | 1995 |
Inhibitors to Coagulation Factors
LM Aledort, LW Hoyer, JM Lusher, HM Reisner, GC White |
1995 | |
Hereditary Diseases and Blood Transfusion
CT Sibinga, PC Das, E Briët |
1995 | |
Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa
TM Hackeng, , JC Meijers, BN Bouma |
The Journal of biological chemistry | 1994 |
The mechanism of inactivation of human factor V and human factor Va by activated protein C
M Kalafatis, MD Rand, KG Mann |
The Journal of biological chemistry | 1994 |
Factor IXa protects factor VIIIa from activated protein C. Factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562
LM Regan, BJ Lamphear, CF Huggins, FJ Walker, PJ Fay |
The Journal of biological chemistry | 1994 |
von Willebrand's disease. Pathogenesis and clinical aspects
S Lethagen |
Critical Reviews in Oncology/Hematology | 1993 |
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
T Koster, JP Vandenbroucke, FR Rosendaal, H Ronde, E Briët, RM Bertina |
The Lancet | 1993 |
Detection of canine carriers of haemophilia A using factor VIII activity and von Willebrand factor antigen concentration
PD Mansell, BW Parry, GA Anderson |
Preventive Veterinary Medicine | 1993 |
Basics of Cutaneous Wound Repair
RA Clark |
The Journal of Dermatologic Surgery and Oncology | 1993 |
Factor VIII: Structure, function and analysis
M Fiona, ÓF Ciarán, OK Richard |
Biotechnology Advances | 1993 |
Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C
TM Hackeng, M Hessing, , F Meijer-Huizinga, JC Meijers, PG de Groot, JA van Mourik, BN Bouma |
The Journal of biological chemistry | 1993 |
High affinity binding of human vitamin K-dependent protein S to a truncated recombinant beta-chain of C4b-binding protein expressed in Escherichia coli
Y Härdig, A Rezaie, B Dahlbäck |
The Journal of biological chemistry | 1993 |
Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation
RJ Wise, BM Ewenstein, J Gorlin, SC Narins, M Jesson, RI Handin |
Human Genetics | 1993 |
A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675–Glu1684inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells
M Shima, A Yoshioka, M Nakajima, H Nakai, H Fukui |
British Journal of Haematology | 1992 |
Further evidence for recessive inheritance of von willebrand disease with abnormal binding of von willebrand factor to factor VIII
MF Lopez-Fernandez, MJ Blanco-Lopez, MP Castiñeira, J Batlle |
American Journal of Hematology | 1992 |
Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely
S Layet, JP Girma, B Obert, E Peynaud-Debayle, N Bihoreau, D Meyer |
Biochemical Journal | 1992 |
Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III
S Lethagen, E Berntorp, IM Nilsson |
Annals of Hematology | 1992 |
ECAT Assay Procedures A Manual of Laboratory Techniques
J Jespersen, RM Bertina, F Haverkate |
1992 | |
Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology
RJ Kaufman |
Annals of Hematology | 1991 |
The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system
M Hessing |
Biochemical Journal | 1991 |
Factor VIII Structure and Function
DN Fass |
Annals of the New York Academy of Sciences | 1991 |
Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII Delta II
S KRISHNAN, HV KOLBE, P LEPAGE, T FAURE, R SAUERWALD, H SALLE, C MULLER, N BIHOREAU, P PAOLANTONACCI, C ROITSCH, P MEULIEN, A PAVIRANI |
European Journal of Biochemistry | 1991 |
Structure-function studies on human C4b-binding protein using monoclonal antibodies
M Hessing, HF Heijnen, TM Hackeng, JJ Sixma, BN Bouma |
European Journal of Immunology | 1991 |
The Association of Factor VIII With von Willebrand Factor
P Lollar |
Mayo Clinic Proceedings | 1991 |
Recombinant Technology in Hemostasis and Thrombosis
LW Hoyer, WN Drohan |
1991 | |
The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets
M Nesheim, DD Pittman, AR Giles, DN Fass, JH Wang, D Slonosky, RJ Kaufman |
The Journal of biological chemistry | 1991 |
The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII
RJ Wise, AJ Dorner, M Krane, DD Pittman, RJ Kaufman |
The Journal of biological chemistry | 1991 |
von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation
PJ Fay, JV Coumans, FJ Walker |
The Journal of biological chemistry | 1991 |
Enhancement of rabbit protein S anticoagulant cofactor activity in vivo by modulation of the protein S C4B binding protein interaction
RE Weinstein, FJ Walker |
Journal of Clinical Investigation | 1990 |
The effect of von Willebrand factor on activation of factor VIII by factor Xa
JA KOEDAM, RJ HAMER, NH BEESER-VISSER, BN BOUMA, JJ SIXMA |
European Journal of Biochemistry | 1990 |
Characterization of human factor VIII and interaction with von Willebrand factor. An electron microscopic study
HF HEIJNEN, JA KOEDAM, H SANDBERG, NH BEESER-VISSER, JW SLOT, JJ SIXMA |
European Journal of Biochemistry | 1990 |
6 Von Willebrand factor and platelet function
D Baruch, B Bahnak, JP Girma, D Meyer |
Baillière's Clinical Haematology | 1989 |
An Overview of Hemostasis
GC Troy |
Veterinary Clinics of North America Small Animal Practice | 1988 |
The Molecular and Cellular Biology of Wound Repair
RA Clark, PM Henson |
1988 | |
Hematology
JJ Shea, JJ Shea |
The Laryngoscope | 1949 |